Professor Risteárd Ó Laoide:

It is important to say that we are appointing a national lead for molecular diagnostics who will be appointed into the position in early 2021. That person will lead out on the development of this framework. More generally in genetic medicine we are also appointing, early in 2021, a national lead for genomic medicine and the genomic network, and that recruitment process is under way. This person will lead on the development of genomic medicine and the treatment of hereditary cancers.